Cite

HARVARD Citation

    Ferenci, P. et al. (n.d.). A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa‐2a (40kD)/ribavirin. Liver international. pp. 1550-1559. [Online]. 
  
Back to record